Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Osprey Pharmaceuticals USA

Request full access

Novel protein therapeutics for inflammatory and immune diseases

San Francisco, United StatesFounded 1998Biotechnology

About Osprey Pharmaceuticals USA

Osprey Pharmaceuticals U.S.A., Inc. is a clinical-stage biopharmaceutical company focused on creating protein therapeutics to treat inflammatory and autoimmune conditions. Founded in 2008, the company operates as the U.S. arm to develop drugs emerging from its Canadian parent company, Osprey Pharmaceuticals Ltd. The firm is headquartered in San Francisco, California. The leadership team included Jack M. Anthony as Chief Executive Officer and Barbara K. Finck, M.D., as Chief Medical Officer.

The company's core technology revolves around its proprietary Leukocyte Population Modulators (LPMs), which are novel fusion protein therapeutics. These LPMs are engineered to selectively identify and eradicate disease-causing leukocytes by targeting the chemokine system, which regulates the movement and activity of these immune cells. This approach aims to neutralize chemokine-activated leukocytes that are responsible for initiating and perpetuating a variety of inflammatory and immune diseases.

Osprey’s lead product candidate, known as CCL2-LPM, is a therapeutic fusion protein designed to target the CCL2-CCR2 chemokine axis. This biological pathway is significant in conditions like inflammatory kidney diseases. In 2008, the company secured $11 million in its first venture capital funding round, led by Burrill & Company, to advance CCL2-LPM into clinical trials and further develop its LPM discovery platform. By 2025, total funding had reached $14.9 million over three rounds. The company's lead candidate entered a Phase Ib clinical trial for treating IgA nephropathy.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
17.0/100
Client focus
B2C

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2009 — — Undisclosed —
DEBT✓Debt May 2009 $5.9M — Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Osprey Pharmaceuticals USA website traffic

Latest recorded traffic for Osprey Pharmaceuticals USA is 150 monthly website visits, up 0% over the last three months.

Latest monthly visits150 3-month web change0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Osprey Pharmaceuticals USA in the San Francisco ecosystem

Live from Dealroom

The Osprey Pharmaceuticals USA office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later1 investor entered at this stage

  • Ventures West

Other known investors2 additional known investors

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Francisco HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Osprey Pharmaceuticals USA on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Osprey Pharmaceuticals USA’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.